Bausch Health
546 hedge funds and large institutions have $53.2B invested in Bausch Health in 2015 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 197 increasing their positions, 211 reducing their positions, and 103 closing their positions.
2.62% more ownership
Funds ownership: 84.87% → 87.49% (+2.6%)
7% less repeat investments, than reductions
Existing positions increased: 197 | Existing positions reduced: 211
6% less funds holding in top 10
Funds holding in top 10: 89 → 84 (-5)
6% less funds holding
Funds holding: 582 → 546 (-36)
17% less capital invested
Capital invested by funds: $64.4B → $53.2B (-$11.2B)
33% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 103
48% less call options, than puts
Call options by funds: $1.03B | Put options by funds: $1.97B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$1.51B |
| 2 |
JP Morgan Chase
New York
|
+$637M |
| 3 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$502M |
| 4 |
HP
Hound Partners
New York
|
+$271M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$230M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Institutional Capital
Chicago,
Illinois
|
-$335M |
| 2 |
JP
Jana Partners
New York
|
-$298M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$209M |
| 4 |
Barclays
London,
United Kingdom
|
-$183M |
| 5 |
Millennium Management
New York
|
-$183M |
BHC Hedge Fund Activity: Q3 2015 in Review
546 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2015, worth a combined $53.2B — down 17% from $64.4B a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of BHC and 69 opened new positions — a net loss of 34 holders — while 211 trimmed existing stakes and 197 added.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), adding an estimated $1.51B. The largest seller was Institutional Capital, exiting entirely with an estimated $335M sold.
- 546 institutional investors held Bausch Health (BHC) as of Q3 2015, down from 582 in Q2 2015.
- Funds reported $53.2B of Bausch Health stock for Q3 2015, down 17% quarter-over-quarter.
- 69 funds opened new Bausch Health positions in Q3 2015 and 103 closed out, a net change of -34 holders.
- The largest Bausch Health buyer in Q3 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $1.51B added.
- The largest Bausch Health seller in Q3 2015 was Institutional Capital, an estimated $335M sold.
Based on aggregated 13F filings for Q3 2015.